A single dose, randomized, double blind, double dummy, placebo controlled, three-period crossover clinical study, comparing the onset of relief from methacholine induced bronchoconstriction with fixed combination beclomethasone dipropionate 100 microg plus formoterol fumarate 6 microg/actuation pMDI with HFA-134a propellant (Foster) versus standard salbutamol pMDI 100 microg/actuation (Ventolin Evohaler) therapy in asthmatic patients.

Trial Profile

A single dose, randomized, double blind, double dummy, placebo controlled, three-period crossover clinical study, comparing the onset of relief from methacholine induced bronchoconstriction with fixed combination beclomethasone dipropionate 100 microg plus formoterol fumarate 6 microg/actuation pMDI with HFA-134a propellant (Foster) versus standard salbutamol pMDI 100 microg/actuation (Ventolin Evohaler) therapy in asthmatic patients.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Oct 2012

At a glance

  • Drugs Beclometasone/formoterol; Salbutamol
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms MART-1
  • Sponsors Chiesi
  • Most Recent Events

    • 02 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top